Recombinant Human Active Raf-1 (Y340E Y341E, 306-end), CF

(2 citations)   
  • Purity
    >70%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie® Blue stain at 5 μg per lane
  • Activity
    The activity of Raf-1 is typically 5100-6900 nmol/min/mg using a myelin basic protein (MBP) substrate (see Activity Assay Protocol).
  • Source
    Spodoptera frugiperda, Sf 9 (baculovirus)-derived aa 306-648 Accession # NM_002880
  • Accession #
  • N-terminal Sequence
    Using an N-terminal GST tag
  • Predicted Molecular Mass
    63  kDa
Formulation Supplied in 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.25 mM DTT, 10 mM glutathione, 0.1 mM EDTA, 0.1 mM PMSF, and 25% glycerol.
Shipping The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: This product is stable at ≤ ‑70° C for up to 1 year from the date of receipt. For optimal storage, aliquot into smaller quantities after centrifugation and store at recommended temperature. Avoid repeated freeze-thaw cycles.
Assay Procedure
  • Active Kinase - Active Raf-1(EE) (0.1 μg/μL) diluted with Kinase Dilution Buffer III and assayed as outlined in Figure 2. Note: These are suggested working dilutions. Optimal dilutions should be determined by each laboratory for each application.
  • Kinase Assay Buffer I, pH 7.2 - 25 mM MOPS, 12.5 mM beta -glycerolphosphate, 25 mM MgCl2, 5 mM EGTA, 2 mM EDTA. Add 0.25 mM DTT to the Kinase Assay Buffer prior to use.
  • Kinase Dilution Buffer III, pH 7.2 - Kinase Assay Buffer I diluted at a 1:4 ratio (5-fold dilution) with 50 ng/μL BSA solution.
  • 10 mM ATP Stock Solution - Prepare the ATP Stock Solution by dissolving 55 mg of ATP in 10 mL of Kinase Assay Buffer I. Store 200 μL aliquots at ≤ -20 °C.
  • [33P]-ATP Assay Cocktail - Prepare 250 μM [33P]-ATP Assay Cocktail in a designated radioactive work area by combining 150 μL of 10 mM ATP Stock Solution, 100 μL of [33P]-ATP (1 mCi/100 μL), and 5.75 mL of Kinase Assay Buffer I. Store 1 mL aliquots at
    ≤ -20 °C.
  • Substrate - Inactive MEK1 and ERK1 were activated in a coupled reaction. Myelin Basic Protein (MBP) substrate diluted in distilled or deionized water to a final concentration of 1 mg/mL was subsequently used as a substrate for the activated ERK1.
  1. Thaw the [33P]-ATP Assay Cocktail in a shielded container in a designated radioactive work area.
  2. Thaw the Active Raf-1 (EE), Kinase Assay Buffer I, inactive ERK1, and inactive MEK1 on ice.
  3. In a pre-cooled microfuge tube, add the following reaction components bringing the initial reaction volume up to 20 μL.
    a. Diluted Active Raf-1(EE): 10 μL
    b. Inactive ERK1 (0.2 μg/mL): 1 μL
    c. Inactive MEK1 (0.2 μg/mL): 1 μL
    d. Kinase Dilution Buffer: 8 μL
  4. Start the reaction with the addition of 5 μL ATP (250 μM) and incubate in a water bath at 30 °C for 15 minutes.
  5. After the 15 minute incubation, remove 5 μL and add it to the following reaction components on ice, bringing the initial reaction volume up to 20 μL.
    a. Reaction Mixture: 5 μL
    b. Distilled or deionized water (on ice): 10 μL
    c. MBP Substrate (1 mg/mL; on ice): 5 μL
  6. Set up the blank control as outlined in step 5, excluding the addition of the substrate. Replace the substrate with an equal volume of distilled or deionized water.
  7. Initiate the reaction with the addition of 5 μL [33P]-ATP Assay Cocktail, bringing the final volume up to 25 μL. Incubate the mixture in a water bath at 30 °C for 15 minutes.
  8. After the 15 minute incubation, terminate the reaction by spotting 20 μL of the reaction mixture onto individual pre-cut strips of phosphocellulose P81 paper.
  9. Air dry the pre-cut P81 strip and sequentially wash in a 1% phosphoric acid solution (dilute 10 mL of phosphoric acid and make a 1 liter solution with distilled or deionized water) with constant gentle stirring. It is recommended that the strips be washed a total of three times for approximately 10 minutes each.
  10. Count the radioactivity on the P81 paper in the presence of scintillation fluid in a scintillation counter.
  11. Determine the corrected cpm by removing the blank control value (see step 6) for each sample and calculate the kinase specific activity as outlined below:

    Calculation of [33P]-ATP Specific Activity (SA) (cpm/pmol)
    Specific Activity (SA) = cpm for 5 μL [33P]-ATP/pmol of ATP (in 5 μL of a 250 μM ATP stock solution; i.e. 1250 pmol)

    Calculation of Kinase Specific Activity (SA) (pmol/minutes/μg or nmol/minutes/mg)
    Corrected cpm from reaction / [(SA of 33P-ATP in cpm/pmol) x (Reaction time in minutes) x (Enzyme amount in μg or mg)] x [(Reaction volume) / (Spot Volume)]
Data Images
The approximate molecular weight is 63 kDa and the average purity is 85%.
Background: Raf-1

Raf-1 is a MAP kinase kinase kinase (MAP3K), which functions downstream of the Ras family of membrane associated GTPases to which it binds directly (1). The activated Raf-1 can phosphorylate and activate the dual specificity protein kinases MEK1 and MEK2, which in turn phosphorylate to activate the Serine/Threonine specific protein kinases ERK1 and ERK2. Activated ERKs are pleiotropic effectors of cell physiology and play an important role in the control of gene expression involved in the cell division cycle, apoptosis, cell differentiation, and cell migration (2).

  • References:
    1. Rapp, U. et al. (1983) Proc. Natl. Acad. Sci. USA 80:4218.
    2. Li, P. et al. (1991) Cell 64:479.
  • Long Name:
    v-raf-1Murine Leukemia Viral Oncogene Homolog 1
  • Entrez Gene IDs:
    5894 (Human); 110157 (Mouse); 24703 (Rat)
  • Alternate Names:
    cRaf; c-Raf; c-Raf-1; CRAFraf proto-oncogene serine/threonine protein kinase; EC 2.7.11; EC; NS5; Proto-oncogene c-RAF; RAF proto-oncogene serine/threonine-protein kinase; RAF; Raf1; Raf-1Oncogene RAF1; v-raf-1 murine leukemia viral oncogene homolog 1; v-Raf-1
Related Research Areas

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

Showing Results 1 - 2 of 2
Filter your results:

Sample Type
  1. Epidermal Growth Factor-dependent Activation of the Extracellular Signal-regulated Kinase Pathway by DJ-1 Protein through Its Direct Binding to c-Raf Protein.
    Authors: Takahashi-Niki K, Kato-Ose I, Murata H, Maita H, Iguchi-Ariga S, Ariga H
    J Biol Chem, 2015;290(29):17838-47.
    Species: not specified
    Sample Type: recombinant protein
    Application: Bioassay
  2. BDNF alters ERK/p38 MAPK activity ratios to promote differentiation in growth plate chondrocytes.
    Mol. Endocrinol., 2012;26(8):1406-16.
    Species: Human
    Sample Type: recombinant p38
    Application: Kinase Assay

Have you used Recombinant Human Active Raf-1 (Y340E Y341E, 306-end), CF?

Submit a review and receive a $25 amazon gift card if you include an image - $10 Amazon card for reviews without an image. Limited to verified customers in USA, Canada and Europe.

Order Details

    Contact Information

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

Certificate of Analysis Lookup

The document you requested is not available online. Please enter the Catalog Number and Lot Number below to have a document emailed to you at the address provided

Certificate of Analysis Lookup

Research Areas of Interest
R&D Systems Guarantee


Customer Information